CC
ELV icon

Cognios Capital’s Elevance Health ELV Stock Holding History

Cognios Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,910
Closed -$1.03M – 140
2018
Q4 		$1.03M Buy
+3,910
New +$1.08M 0.41% 109
2017
Q4 		– Sell
-9,154
Closed -$1.74M – 170
2017
Q3 		$1.74M Sell
9,154
-3,505
-28% -$667K 0.7% 91
2017
Q2 		$2.38M Buy
+12,659
New +$2.27M 0.83% 55
2014
Q4 		– Sell
-10,387
Closed -$1.24M – 82
2014
Q3 		$1.24M Buy
+10,387
New +$1.19M 0.87% 40

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cognios Capital's ELV Position: Q1 2019 in Review

Cognios Capital sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 3,910 shares — an estimated $1.03M sold.

Cognios Capital first reported a position in ELV in Q3 2014 and held it in 4 quarters. The position peaked at $2.38M in Q2 2017. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Cognios Capital reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Cognios Capital sold 3,910 Elevance Health shares in Q1 2019, an estimated $1.03M.
  • Cognios Capital first reported a position in Elevance Health in Q3 2014 and held it in 4 quarters.
  • Cognios Capital's Elevance Health position peaked at $2.38M in Q2 2017.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Cognios Capital's 13F filing for Q1 2019, filed 13 May 2019.